
Researchers identify a novel host-directed therapeutic approach to COVID-19
Researchers in the UK have demonstrated the potential of modulating the expression of angiotensin-converting enzyme 2 (ACE2) as a novel host-directed therapeutic approach to protecting against coronavirus disease 2019 (COVID-19). The human ACE2 receptor is the main host structure that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to as the initial stage of the infection process. “Because host-directed treatments […]
Read more